- Home
- BIGC vs FDMT Comparison
BIGC vs FDMT Comparison
Compare BIGC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIGC
- FDMT
- Stock Information
- Founded
- BIGC 2009
- FDMT 2013
- Country
- BIGC United States
- FDMT United States
- Employees
- BIGC N/A
- FDMT N/A
- Industry
- BIGC Computer Software: Prepackaged Software
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- BIGC Technology
- FDMT Health Care
- Exchange
- BIGC Nasdaq
- FDMT Nasdaq
- Market Cap
- BIGC 432.3M
- FDMT 420.7M
- IPO Year
- BIGC 2020
- FDMT 2020
- Fundamental
- Price
- BIGC $6.37
- FDMT $8.41
- Analyst Decision
- BIGC Hold
- FDMT Strong Buy
- Analyst Count
- BIGC 9
- FDMT 9
- Target Price
- BIGC $8.61
- FDMT $46.75
- AVG Volume (30 Days)
- BIGC 918.8K
- FDMT 759.8K
- Earning Date
- BIGC 11-07-2024
- FDMT 11-13-2024
- Dividend Yield
- BIGC N/A
- FDMT N/A
- EPS Growth
- BIGC N/A
- FDMT N/A
- EPS
- BIGC N/A
- FDMT N/A
- Revenue
- BIGC $330,048,000.00
- FDMT $17,000.00
- Revenue This Year
- BIGC $9.74
- FDMT N/A
- Revenue Next Year
- BIGC $5.39
- FDMT $57.85
- P/E Ratio
- BIGC N/A
- FDMT N/A
- Revenue Growth
- BIGC 10.87
- FDMT N/A
- 52 Week Low
- BIGC $5.13
- FDMT $7.32
- 52 Week High
- BIGC $10.19
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- BIGC 61.56
- FDMT 45.52
- Support Level
- BIGC $5.89
- FDMT $8.04
- Resistance Level
- BIGC $6.83
- FDMT $9.18
- Average True Range (ATR)
- BIGC 0.33
- FDMT 0.57
- MACD
- BIGC 0.05
- FDMT 0.19
- Stochastic Oscillator
- BIGC 68.98
- FDMT 58.60
About BIGC BigCommerce Holdings Inc. Series 1
BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.